Literature DB >> 19437355

Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature.

John Nguyen1, Aaron Fay.   

Abstract

Infantile hemangiomas are common vascular tumors of childhood with a propensity for the head and neck. In the periocular region, they can cause functional and cosmetic deformity. The proliferation and involution of hemangiomas are controlled by complex interactions of molecular, cellular, and hormonal regulators. There is no single uniformly safe and effective treatment option. Various modalities, including local and systemic pharmacologic agents, lasers, surgery and embolization, are employed to halt growth and to induce regression. This article will review the rapidly evolving field of pharmacologic treatment of infantile hemangiomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437355     DOI: 10.1080/08820530902805602

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  20 in total

1.  Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration.

Authors:  Jinsong Hao; Michael B Yang; Hongzhuo Liu; S Kevin Li
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-02       Impact factor: 2.671

2.  Use of propranolol in infantile haemangiomas: report of five cases and review of the literature.

Authors:  D Gidaris; M Economou; V Hatzidemetriou; N Gombakis; M Athanassiou-Metaxa
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 3.  [Current aspects of eyelid, lacrimal and orbital surgery in childhood].

Authors:  G Avgitidou; K R Koch; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

Review 4.  Educational paper: therapy of infantile haemangioma--history and current state (part II).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-09-03       Impact factor: 3.183

5.  Phytochemical Inhibition of Multidrug Resistance Protein-1 as a Therapeutic Strategy for Hemangioendothelioma.

Authors:  Ayan Biswas; Emma C Clark; Chandan K Sen; Gayle M Gordillo
Journal:  Antioxid Redox Signal       Date:  2016-11-09       Impact factor: 8.401

6.  Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.

Authors:  M Snir; U Reich; R Siegel; A Zvulunov; R Friling; N Goldenberg-Cohen; Y Ron; D Ben-Amitay
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

Review 7.  Update on pediatric extracranial vascular anomalies of the head and neck.

Authors:  Katherine B Puttgen; Monica Pearl; Aylin Tekes; Sally E Mitchell
Journal:  Childs Nerv Syst       Date:  2010-08-10       Impact factor: 1.475

8.  Periocular capillary hemangiomas: indications and options for treatment.

Authors:  Genie M Bang; Pete Setabutr
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

Review 9.  The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies.

Authors:  Yin Lou; Wen-jia Peng; Yi Cao; Dong-sheng Cao; Juan Xie; Hong-hong Li
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

10.  Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.

Authors:  Qiang Xiao; Qin Li; Bin Zhang; Wenlin Yu
Journal:  Pediatr Surg Int       Date:  2013-03-22       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.